Johnson & Johnson stock jumped Wednesday after the Dow health behemoth raised its guidance in the wake of a bullish second-quarter report.
Dow’s J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific
view original post